beta-1, 4-GalNAc-T Antibody from MYBIOSOURCE INC.
Search, find, compare suppliers for anti-beta-1, 4-GalNAc-T antibody, protein, ELISA kits.
| Edit | |
|---|---|
| Antigenic Specificity | beta-1, 4-GalNAc-T |
| Clone | polyclonal |
| Host Species | Rabbit |
| Reactive Species | human, mouse, rat |
| Isotype | n/a |
| Format | immunogen affinity purified |
| Size | 0.03 mL, 0.1 mL, 0.2 mL |
| Concentration | 1 mg/ml |
| Applications | Western Blot (WB), Immunohistochemistry (IHC) Paraffin, ELISA (EIA) |
| Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
| Description | Specificity: beta-1,4-GalNAc-T Polyclonal Antibody detects endogenous levels of beta-1,4-GalNAc-T protein. CSGALNACT1 (Chondroitin Sulfate N-Acetylgalactosaminyltransferase 1) is a Protein Coding gene. Diseases associated with CSGALNACT1 include bell's palsy. Among its related pathways are Defective B3GAT3 causes JDSSDHD and Metabolism. GO annotations related to this gene include glucuronosyltransferase activity and glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity. An important paralog of this gene is B4GALNT4. |
| Immunogen | Immunogen: Synthesized peptide derived from the internal region of human beta-1,4-GalNAc-T at AA range: 180-260 |
| Other Names | [Rabbit beta-1,4-GalNAc-T; CSGALNACT1; CHGN; GALNACT1; Chondroitin sulfate N-acetylgalactosaminyltransferase 1; CsGalNAcT-1; Chondroitin beta-1; 4-N-acetylgalactosaminyltransferase 1; Beta4GalNAcT-1] |
| Gene, Accession # | [beta-1,4-GalNAc-T], Gene ID: 55790, NCBI: NP_001123990.1, UniProt: Q8TDX6 |
| Catalog # | MBS9706400 |
| Price | $130, $220, $325 |
| Order / More Info | beta-1, 4-GalNAc-T Antibody from MYBIOSOURCE INC. |
| Product Specific References | n/a |
MYBIOSOURCE INC.
MYBIOSOURCE INC.
P.O. Box 153308
San Diego CA 92195-3308
P: 1.858.633.0165
P: 1.888.MBS.0165 (1.888.627.0165) (US & Canada)
F: 1.858.633.0166
sales@mybiosource.com
http://www.MyBioSource.com
Profile of MYBIOSOURCE INC.
Return to Antibodies